Penghua CSI Medical and Health Index Securities Investment Fund (LOF) (abbreviation: Penghua CSI Pharmaceutical Index A (LOF), code 160635) announced its latest net value on September 20, down 1.00%.
Penghua CSI Pharmaceutical Index A (LOF) was established on July 15, 2016, and the performance comparison benchmark is the yield of the CSI Medical and Health Index ×95% + the current deposit interest rate of commercial banks (after tax) ×5%. The fund has returned -25.72% since its inception, -24.28% this year, -4.34% over the past month, -24.89% over the past year, and -48.42% over the last three years. In the past year, the fund ranked 2729/3264 in its peer group.
The fund manager is Zhang Yuxiang. Zhang Yuxiang has managed (or intends to manage) the fund since August 24, 2021, with a return of -48.74% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 300760 | Mindray Medical | 9.57%, | 33800 | 9.8328 million |
| 600276 | Hengrui Pharmaceutical | 9.31% | 248711 | 9.5654 million |
| 603259 | WuXi AppTec | 5.38% | 141015 | 5.5264 million |
| 600436 | Pien Tze Huang | 3.39%, | 16800 | 3.4805 million |
| 300015 | Aier Ophthalmology | 2.62% | 260401 | 2.6873 million |
| 000538 | Yunnan Baiyao | 2.48% | 49860 | 2.5503 million |
| 002252 | Shanghai RAAS | 2.26% | 296908 | 2.3218 million |
| 688271 | United Imaging Medical | 1.97%, | 18456 | 2.0246 million |
| 002001 | Xinhecheng | 1.93% | 103508 | 1.9874 million |
| 300122 | Zhifei Biotech | 1.82% | 66800 | 1.8724 million |
Ticker Name
Percentage Change
Inclusion Date
